Innovest Global, Inc. (IVST)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Innovest Global, Inc. (IVST) with AI Score 45/100 (Weak). Innovest Global, Inc. operates across commercial and industrial, energy, and biotechnology sectors. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 16, 2026Innovest Global, Inc. (IVST) Industrial Operations Profile
Innovest Global, Inc., operating within the industrials sector, focuses on diverse business lines including curtain wall systems, energy services, and biotechnology. With a presence in commercial and industrial sectors, the company also supplies safety equipment and develops immunotherapeutics, positioning itself as a diversified conglomerate.
Investment Thesis
Innovest Global, Inc. presents a high-risk, high-reward investment profile due to its presence in multiple sectors, including biotechnology. The company's negative P/E ratio and profit margin of -59.3% indicate financial challenges. Growth catalysts include potential advancements in its immunotherapeutic development and expansion of its energy services. However, the company's OTC listing and negative beta of -0.72 suggest volatility and limited correlation with the broader market. Investors should closely monitor the company's ability to improve profitability and capitalize on its diverse business segments.
Based on FMP financials and quantitative analysis
Key Highlights
- Operates in diverse sectors including commercial and industrial, energy, and biotechnology.
- Gross Margin of 34.0% indicates potential for profitability in specific segments.
- Negative Profit Margin of -59.3% reflects current financial challenges.
- Market Cap of $0.00B indicates a micro-cap company with associated risks and potential for growth.
- Beta of -0.72 suggests a negative correlation with the market, potentially offering diversification benefits.
Competitors & Peers
Strengths
- Diversified operations across multiple sectors.
- Expertise in curtain wall systems design and engineering.
- Potential for breakthrough in glioblastoma multiforme treatment.
- Established presence in energy services and safety equipment supply.
Weaknesses
- Negative profit margin and financial instability.
- OTC listing indicates higher risk and lower liquidity.
- Limited market capitalization and brand recognition.
- Dependence on external factors for energy services demand.
Catalysts
- Upcoming: Potential positive results from clinical trials of its immunotherapeutic for glioblastoma multiforme.
- Ongoing: Expansion of energy services and securing new contracts.
- Ongoing: Increased demand for curtain wall systems in commercial construction projects.
- Ongoing: Strategic partnerships and acquisitions to expand market reach.
Risks
- Potential: Failure in clinical trials for its immunotherapeutic development.
- Potential: Intense competition in all operating sectors.
- Ongoing: Negative profit margin and financial instability.
- Ongoing: OTC listing indicating higher risk and lower liquidity.
- Potential: Economic downturn affecting construction and industrial demand.
Growth Opportunities
- Expansion of Energy Services: Innovest Global has the opportunity to expand its energy services to meet the growing demand for energy-efficient solutions. The energy services market is projected to reach $120 billion by 2028, driven by increasing awareness of energy conservation and government incentives. By leveraging its expertise in LED lighting and energy brokerage, Innovest can capture a larger share of this market. Timeline: Ongoing.
- Development of Immunotherapeutic for Glioblastoma Multiforme: The company's development of immunotherapeutic for glioblastoma multiforme represents a significant growth opportunity. The global glioblastoma multiforme treatment market is expected to reach $2.5 billion by 2027. Successful development and commercialization of this therapeutic could generate substantial revenue. Timeline: 3-5 years.
- Increased Demand for Curtain Wall Systems: Innovest Global can capitalize on the increasing demand for curtain wall systems in commercial and industrial construction. The global curtain wall market is projected to reach $50 billion by 2025, driven by urbanization and the need for energy-efficient building solutions. By enhancing its design and manufacturing capabilities, Innovest can secure more projects. Timeline: Ongoing.
- Supply of Personal Protective Equipment (PPE): The ongoing need for personal protective equipment (PPE) presents a sustained growth opportunity. The global PPE market is expected to remain strong due to health and safety regulations. Innovest Global can expand its supply chain and distribution network to meet this demand, focusing on quality and competitive pricing. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Innovest Global can pursue strategic partnerships and acquisitions to expand its market reach and service offerings. Collaborating with other companies in the energy, construction, and biotechnology sectors can provide access to new technologies, markets, and expertise. Targeted acquisitions can complement its existing business lines and accelerate growth. Timeline: 1-3 years.
Opportunities
- Expansion of energy services to meet growing demand.
- Commercialization of immunotherapeutic for glioblastoma multiforme.
- Increased demand for curtain wall systems in construction.
- Strategic partnerships and acquisitions to expand market reach.
Threats
- Intense competition in all operating sectors.
- Regulatory changes impacting energy and healthcare industries.
- Economic downturn affecting construction and industrial demand.
- Potential failure in clinical trials for immunotherapeutic development.
Competitive Advantages
- Diversified business operations across multiple sectors reduces reliance on a single market.
- Proprietary designs and engineering expertise in curtain wall systems.
- Established relationships with suppliers and customers in the energy and safety equipment sectors.
- Potential for intellectual property protection related to its immunotherapeutic development.
About IVST
Innovest Global, Inc., established in 1999 and based in Chesterland, Ohio, operates as a diversified conglomerate engaging in commercial and industrial, energy, and biotechnology and health services sectors. Originally named Aurum Resource and Asset Management, Inc., the company rebranded to Innovest Global, Inc. in January 2017. Its commercial and industrial segment designs, engineers, tests, and manufactures curtain wall systems, along with negotiating and purchasing various exterior building products. It also supplies personal protection equipment, apparel, and safety supplies. In the energy sector, Innovest Global provides energy services aimed at reducing businesses' overall energy costs, offers LED lighting products, and acts as an independent energy broker. The biotechnology and health services segment focuses on developing immunotherapeutics for treating patients with glioblastoma multiforme. The company also offers inbound and outbound call services.
What They Do
- Designs, engineers, tests, and manufactures curtain wall systems.
- Supplies personal protection equipment, apparel, and safety supplies.
- Offers inbound and outbound call services.
- Negotiates and purchases various exterior building products.
- Provides energy services to reduce businesses overall energy costs.
- Offers LED lighting products.
- Acts as an independent energy broker.
- Develops immunotherapeutic for treating patients with glioblastoma multiforme.
Business Model
- Generates revenue through the sale of curtain wall systems and related engineering services.
- Earns income from the supply of personal protection equipment and safety supplies.
- Provides energy services and earns commissions as an independent energy broker.
- Seeks to generate revenue through the development and potential commercialization of immunotherapeutics.
Industry Context
Innovest Global, Inc. operates within the industrials sector, specifically as a conglomerate. This sector is characterized by companies with diverse business operations across multiple industries. The competitive landscape includes companies like BCND, CBCA, LSCG, MEGH and MGLI. Market trends include increasing demand for energy-efficient solutions and advancements in biotechnology. Innovest Global's diversified approach allows it to capitalize on various market opportunities, but also presents challenges in managing diverse operations and maintaining profitability.
Key Customers
- Commercial and industrial construction companies requiring curtain wall systems.
- Businesses seeking to reduce energy costs through energy services and LED lighting.
- Organizations requiring personal protection equipment and safety supplies.
- Patients and healthcare providers seeking innovative treatments for glioblastoma multiforme.
Financials
Chart & Info
Innovest Global, Inc. (IVST) stock price: Price data unavailable
Latest News
No recent news available for IVST.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IVST.
Price Targets
Wall Street price target analysis for IVST.
MoonshotScore
What does this score mean?
The MoonshotScore rates IVST's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry ConglomeratesLeadership: Sri Vanamali
CEO
Sri Vanamali serves as the CEO of Innovest Global, Inc. His background includes experience in strategic leadership and business development. He has been instrumental in guiding the company through its transition and diversification efforts. His expertise spans across various sectors, including energy, biotechnology, and industrial solutions. Vanamali's leadership focuses on driving innovation and creating shareholder value through strategic initiatives and operational efficiency.
Track Record: Under Sri Vanamali's leadership, Innovest Global, Inc. has focused on diversifying its business operations and exploring new growth opportunities. Key milestones include the expansion of energy services and the development of immunotherapeutic for glioblastoma multiforme. His strategic decisions have aimed to position the company for long-term growth and sustainability, despite current financial challenges.
IVST OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Innovest Global, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater price volatility. Unlike NYSE or NASDAQ listings, OTC Other stocks do not have the same stringent listing requirements, resulting in increased risks for investors due to potential lack of transparency and regulatory oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Potential for price manipulation due to low trading volume.
- Higher risk of delisting or trading suspension.
- Lack of regulatory oversight compared to listed exchanges.
- Increased volatility and wider bid-ask spreads.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor experienced in OTC stocks.
- Confirm the company's contact information and physical address.
- Company has been in operation since 1999.
- Diversified business operations across multiple sectors.
- Development of immunotherapeutic for a serious medical condition.
- Presence in commercial and industrial sectors with tangible products.
- Company leadership with experience in strategic development.
IVST Industrials Stock FAQ
What does Innovest Global, Inc. do?
Innovest Global, Inc. operates as a diversified conglomerate with a focus on commercial and industrial, energy, and biotechnology sectors. The company designs and manufactures curtain wall systems, supplies personal protective equipment, and offers energy services aimed at reducing energy costs for businesses. Additionally, Innovest Global is involved in the development of immunotherapeutics for treating glioblastoma multiforme, showcasing its diverse business model.
What do analysts say about IVST stock?
As of 2026-03-16, there is no readily available analyst coverage for Innovest Global, Inc. due to its OTC listing and small market capitalization. Investors should conduct their own due diligence and consider the company's financial challenges, growth opportunities, and inherent risks associated with OTC stocks. Key metrics to monitor include revenue growth, gross margin, and progress in its biotechnology initiatives.
What are the main risks for IVST?
The main risks for Innovest Global, Inc. include its negative profit margin, OTC listing indicating higher risk and lower liquidity, and the potential failure in clinical trials for its immunotherapeutic development. Additionally, the company faces intense competition in all operating sectors and is vulnerable to economic downturns affecting construction and industrial demand. Investors should carefully assess these risks before investing.
What are the key factors to evaluate for IVST?
Innovest Global, Inc. (IVST) currently holds an AI score of 45/100, indicating low score. Key strength: Diversified operations across multiple sectors.. Primary risk to monitor: Potential: Failure in clinical trials for its immunotherapeutic development.. This is not financial advice.
How frequently does IVST data refresh on this page?
IVST prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven IVST's recent stock price performance?
Recent price movement in Innovest Global, Inc. (IVST) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified operations across multiple sectors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider IVST overvalued or undervalued right now?
Determining whether Innovest Global, Inc. (IVST) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying IVST?
Before investing in Innovest Global, Inc. (IVST), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited due to OTC status.
- AI analysis pending for IVST.